Most cited papers from Ospedale di Belcolle

Ospedale di Belcolle

What are the most cited papers from Ospedale di Belcolle?

The most cited paper from Ospedale di Belcolle is "The Intestinal Wnt/TCF Signature" (Laurens G. van der Flier, Jacob Sabates–Bellver, Irma M. Oving et al., 2006), with 513 citations. Next come "Transcriptome Profile of Human Colorectal Adenomas" (508) and "Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial" (478).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 81 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The Intestinal Wnt/TCF Signature Laurens G. van der Flier, Jacob Sabates–Bellver, Irma M. Oving et al. · Gastroenterology	21 Aug 2006	513
2	Transcriptome Profile of Human Colorectal Adenomas Jacob Sabates–Bellver, Laurens G. van der Flier, Mariagrazia de Palo et al. · Molecular Cancer Research	Dec 2007	508
3	Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial Marina Chiara Garassino, Olga Martelli, Massimo Broggini et al. · The Lancet Oncology	21 Jul 2013	478
4	Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial Paolo Verdecchia, Jan A. Staessen, Fabio Angeli et al. · The Lancet Open access	Aug 2009	437
5	Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS Augusto Achilli, Massimo Sassara, Sabina Ficili et al. · Journal of the American College of Cardiology Open access	Dec 2003	367
6	Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival Valentina Santi, Franco Trevisani, Annagiulia Gramenzi et al. · Journal of Hepatology Open access	28 Apr 2010	304
7	Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ⩽3cm. Results of a multicenter Italian survey Maurizio Pompili et al. · Journal of Hepatology	22 Mar 2013	297
8	Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial Francesco Scolari, Elisa Delbarba, Domenico Santoro et al. · Journal of the American Society of Nephrology Open access	Mar 2021	252
9	Prognosis of untreated hepatocellular carcinoma Edoardo Giovanni Giannini, Fabio Farinati, Francesca Ciccarese et al. · Hepatology Open access	18 Sep 2014	251
10	Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial Francesco Cognetti et al. · Annals of Oncology Open access	22 Aug 2011	223
11	Contribution of inflammatory pathways to Fabry disease pathogenesis Paula Adriana Rozenfeld, Sandro Feriozzi · Molecular Genetics and Metabolism Open access	13 Sep 2017	220
12	Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study Alessandro Cosolito Vitale et al. · Journal of Hepatology	30 Oct 2014	212
13	Comparison of Recurrence of Hepatocellular Carcinoma After Resection in Patients with Cirrhosis to Its Occurrence in a Surveilled Cirrhotic Population Alessandro Cucchetti, Fabio Piscaglia, Eugenio Caturelli et al. · Annals of Surgical Oncology	26 Nov 2008	196
14	Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy Krzysztof Kiryluk et al. · Nature Genetics Open access188 authors	19 Jun 2023	191
15	Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database Alessandro Cosolito Vitale et al. · Gut Open access	21 Dec 2021	174
16	Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience Federica Mirici-Cappa, Annagiulia Gramenzi, Valentina Santi et al. · Gut	Mar 2010	166
17	Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study Alessandro Cosolito Vitale, Rafael Morales, Giacomo Zanus et al. · The Lancet Oncology	21 Jun 2011	156
18	Prediction of Response to Cardiac Resynchronization Therapy: The Selection of Candidates for CRT (SCART) Study Augusto Achilli, Carlo Peraldo, Massimo Sassara et al. · Pacing and Clinical Electrophysiology	27 Nov 2006	153
19	Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study Eugenio Caturelli, L Solmi, M Anti et al. · Gut Open access	11 Aug 2004	151
20	Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis Edoardo Giovanni Giannini, Simona Marenco, Giacomo Borgonovo et al. · Hepatology Open access	26 Apr 2012	149
21	The changing scenario of hepatocellular carcinoma in Italy: an update Francesca Garuti et al. · Liver International	21 Nov 2020	147
22	Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases Chiara Fallerini et al. · Clinical Genetics	4 Sep 2013	147
23	First molecular identification of the zoonotic parasite Anisakis pegreffii(Nematoda: Anisakidae) in a paraffin-embedded granuloma taken from a case of human intestinal anisakiasis in Italy Simonetta Mattiucci, Michela Paoletti, Francesco Borrini et al. · BMC Infectious Diseases Open access	31 Mar 2011	145
24	Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma Fabio Farinati et al. · PLoS Medicine Open access	26 Apr 2016	143
25	Natural History of Non-Small-Cell Lung Cancer with Bone Metastases Daniele Santini et al. · Scientific Reports Open access	22 Dec 2015	142
26	Opisthorchis felineus, an emerging infection in Italy and its implication for the European Union Edoardo Pozio, Orlando Armignacco, Fabrizio Ferri et al. · Acta Tropica	18 Jan 2013	140
27	Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations Fabio Pilato, Marisa Distefano, Rosalinda Calandrelli · Frontiers in Neurology Open access	14 Feb 2020	139
28	Factors That Affect Efficacy of Ultrasound Surveillance for Early Stage Hepatocellular Carcinoma in Patients With Cirrhosis P. Del Poggio, Stefano Olmi, Francesca Ciccarese et al. · Clinical Gastroenterology and Hepatology	26 Feb 2014	131
29	Arterial Access-Site–Related Outcomes of Patients Undergoing Invasive Coronary Procedures for Acute Coronary Syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non–ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy) Alessandro Sciahbasi, Christian Pristipino, Giuseppe Ambrosio et al. · The American Journal of Cardiology	28 Jan 2009	128
30	Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia Enrico Tiacci et al. · New England Journal of Medicine	12 May 2021	126
31	Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory Maurizio Carcaterra, Cristina Caruso · Medical Hypotheses Open access	23 Nov 2020	125
32	Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice Edoardo Giovanni Giannini et al. · Hepatology Open access	21 Nov 2017	125
33	Triple positive breast cancer: A distinct subtype? Patrizia Vici, Laura Pizzuti, Clara Natoli et al. · Cancer Treatment Reviews Open access	20 Dec 2014	124
34	Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data Margherita Rimini et al. · Liver International Open access	14 Jul 2023	123
35	Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma Alessandro Cucchetti et al. · Journal of Hepatology	6 Apr 2014	123
36	Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center Alessandra Fabi, Alessandra Felici, Giulio Metro et al. · Journal of Experimental & Clinical Cancer Research Open access	18 Jan 2011	122
37	Respiratory impedance and bronchodilator responsiveness in healthy children aged 2–13 years Claudia Calogero, Shannon J. Simpson, Enrico Lombardi et al. · Pediatric Pulmonology Open access	20 Nov 2012	114
38	Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update Rosanna Coppo et al. · Nephrology Dialysis Transplantation Open access185 authors	Sep 2018	113
39	Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma Giuseppe Cabibbo et al. · Journal of Hepatology Open access	10 Feb 2017	112
40	Surveillance for Early Diagnosis of Hepatocellular Carcinoma: Is It Effective in Intermediate/Advanced Cirrhosis? Franco Trevisani, Valentina Santi, Annagiulia Gramenzi et al. · The American Journal of Gastroenterology Open access	7 Jul 2007	109
41	Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy? Stephen Waldek, Sandro Feriozzi · BMC Nephrology Open access	6 May 2014	109
42	High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure. Tommaso Stroffolini, M Menchinelli, Gloria Taliani et al. · PubMed	Jun 1995	106
43	Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? Giovanni Duro et al. · International Journal of Molecular Sciences Open access	23 Nov 2018	101
44	Total laparoscopic bypass for aortoiliac occlusive lesions: 93-case experience Marc Coggia, Isabelle Javerliat, Isabelle Di Centa et al. · Journal of Vascular Surgery Open access	Nov 2004	99
45	The Reproducibility of CIN Diagnoses Among Different Pathologists Paolo Palma, Paolo Giorgi Rossi, Guido Collina et al. · American Journal of Clinical Pathology Open access	18 Jun 2009	97
46	KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy Mirko Marabese, Monica Ganzinelli, Marina Chiara Garassino et al. · Oncotarget Open access	15 Sep 2015	95
47	Conservative treatment of subtalar dislocations Dario Perugia, Attilio Basile, Carlo Massoni et al. · International Orthopaedics Open access	24 Nov 2001	94
48	Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort Rosanna Coppo et al. · Pediatric Nephrology Open access	24 Aug 2016	93
49	Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study Fabio Farinati, Adriana Sergio, Anna Baldan et al. · BMC Cancer Open access	27 Jan 2009	93
50	Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy John Feehally et al. · The Nephron journals/Nephron journals Open access	19 Nov 2015	92

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.